D-Street
June 18, 2025 at 06:27 PM
Sheela Foam – Low Expectations, High Execution Stakes | Delivery is the Key
- FY25 Margins down. Credibility dented. But FY26 is the test, if guidance holds, a rerating path opens.
- Here’s why FY26 could be Sheela Foam’s bounce-back year ⤵️
1️⃣ What Went Wrong in FY25?
🔹Kurlon integration brought higher debt & inefficiencies
🔹₹35 Cr one-time loss from obsolete Kurlon inventory
🔹Interest cost tripled due to acquisition loan
🔹Shift to small towns & online = lower pricing power
🔹Depreciation rose from full-year consolidation
🗣 Amit Kumar Gupta, Group CFO
“The integration of Kurlon led to additional costs and inefficiencies… margins were impacted by one-offs and elevated overheads.”
2️⃣ Numbers That Hurt – FY25 vs YoY
🔹Revenue: ₹3,439 Cr ( +15%)
🔹EBITDA: ₹286 Cr (-5%)
🔹Net Profit: ₹97 Cr (-47%)
🔹EBITDA Margin: 8.3%
🔹PAT Margin: 2.8%
🗣 “Despite volume growth and synergy execution, bottom-line lagged due to sectoral headwinds and financing cost.”
3️⃣ Why FY26 Could Be Different ?
🔹₹250 Cr in cost savings fully executed
🔹Manufacturing footprint streamlined: 18 → 12 units
🔹Lower overheads through admin & freight optimization
🔹 ₹200 Cr asset monetization targeted to cut debt
🔹Interest cost to drop from ₹100 Cr → ₹10-15 Cr
🔹Margin levers now operational, not aspirational
🗣 “We’ve executed major cost savings. FY26 will reflect full synergy benefits.”
4️⃣ FY26 Management Guidance
🔹15% revenue CAGR over next 2-3 years
🔹EBITDA margin target: 13-14% (vs 8.3%)
🔹Aim to become net debt-free in 2-3 years
🔹Growth from premium SKUs, rural expansion, ecommerce
🗣 “Our target is 13-14% EBITDA margin. We’re confident FY26 will show significant improvement.”
5️⃣ Growth Triggers in Motion
🔹1,000+ new EBOs planned in FY26
🔹Rural brand Tarang: 7% of volumes → aiming for 12-15%
🔹Ecommerce revenue: ₹175-200 Cr; targeting 60-80% growth
🔹Furlenco now profitable (ARR ₹300 Cr)
🔹STAQO (IT arm): ₹50 Cr revenue with 28% EBITDA margin
🗣 “Retail and digital levers are scaling up. FY26 is about growth with margin discipline.”
6️⃣ Final Take – From Pain to Pivot
🔹FY25 = Cost drag, execution lag
🔹FY26 = Margin reset, deleveraging trigger
🔹FY27 = Potential re-rating if guidance is met
🗣 “The worst is behind us. FY26 will show what the integrated Sheela Foam can really deliver.”
🧭 Investor Compass View
- This isn’t about flashy growth.
- It’s about profitable recovery.
- If margin guidance plays out, Sheela Foam may wake up as a rerating story
💡 From pain to pivot, Sheela’s re-rating depends on delivery, not promises.
👍
😢
3